Evaluation of impurities level of perindopril tert-butylamine in tablets

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 5, 2007, Pages 1087-1094

  Medenica, M ^a   Ivanovic D ^a   Maskovic M ^b   Jancic B ^a   Malenovic A ^a  

^a Faculty of Pharmacy   (Serbia)

^b Medicines and Medical Devices Agency of Serbia   (Serbia)

Author keywords

High performance liquid chromatography; Impurities; Perindopril tert butylamine; Perindoprilat; Validation

Indexed keywords

[2 2 METHYL 1,4 DIOXOOCTAHYDRO 1H INDOLO(1,2 A)PIPERAZIN 3 YL]PENTANOIC ACID; [2 2 METHYL 1,4 DIOXOOCTAHYDRO 1H INDOLO(1,2 A)PIPERAZIN 3YL]PENTANOIC ACID; [ETHYL 2 METHYL 1,4 DIOXOOCTAHYDRO 1H INDOLO(1,2 A)PIPERAZIN 3YL]PENTANOATE; ACETONITRILE; PERINDOPRIL TERT BUTYLAMINE; PERINDOPRILAT; POTASSIUM DIHYDROGEN PHOSPHATE; PREXANIL; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG IMPURITY; DRUG INDUSTRY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL;

ACETONITRILES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BUFFERS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; HYDROGEN-ION CONCENTRATION; MOLECULAR STRUCTURE; PERINDOPRIL; PHARMACEUTICAL PREPARATIONS; PHOSPHATES; POTASSIUM COMPOUNDS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 34547757006     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.05.008     Document Type: Article

References (23)

1. European Pharmacopoeia, Fifth ed., 2005.
2. Ozoemena K.I., Stefan R.I., van-Staden J.F., and Aboul-Enein H.Y. Talanta 62 (2004) 681-685
3. Stefan R.I., van-Staden J.F., and Aboul-Enein H.Y. Chirality 11 (1999) 631-634
4. Stefan R.I., van-Staden J.F., Mulaudzi L.V., and Aboul-Enein H.Y. Anal. Chim. Acta 467 (2002) 189-195
5. van-Staden J.F., Stefan R.I., and Aboul-Enein H.Y. Fresenius' J. Anal. Chem. 367 (2000) 178-180
6. Stefan R.I., van-Staden J.F., and Aboul-Enein H.Y. Sens. Actuators B B54 (1999) 261-265
7. Emara S., El-Gindy A., El-Shorbagi A.N., and Hadad G. Anal. Chim. Acta 489 (2003) 115-123
8. Abdellatef H.E., Ayad M.M., and Taha E.A. J. Pharm. Biomed. Anal. 18 (1999) 1021-1027
9. Hillaert S., Vander-Heyden Y., and van-den-Bossche W.J. J. Chromatogr. A 978 (2002) 231-242
10. Hillaert S., and van-den-Bossche W. J. Pharm. Biomed. Anal. 25 (2001) 775-783
11. Hillaert S., and van-den-Bossche W. J. Chromatogr. A 895 (2000) 33-42
12. Czerwinska K., Wyszomirska E., and Kaniewska T. Acta Pol. Pharm. 58 (2001) 331-338
13. Lin S.J., Wu H.L., and Wen Y.H. Anal. Lett. 29 (1996) 1751-1762
14. Sereda K.M., Hardman T.C., Dilloway M.R., and Lant A.F. Anal. Proc. (Lond.) 30 (1993) 371-372
15. Tsaconas C., Devissaguet M., and Padieu P. J. Chromatogr. Biomed. Appl. 80 (1989) 249-265
16. Van-den-Berg H., Resplandy G., De-Bie A.T.H.J., Floor W., Bertrand M., and Arts C.J.M. J. Pharm. Biomed. Anal. 9 (1991) 517-524
17. Erk N. J. Pharm. Biomed. Anal. 26 (2001) 43-52
18. Gumieniczek A., and Hopkala H. Chem. Anal. (Warsaw) 43 (1998) 951-954
19. International Conference on Harmonization. Topic Q2B, validation of analytical methods: methodology. The Third International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use (ICH). Yokohama, Japan (1996)
20. Hund E., Vander Heyden Y., Haustein M., Massart D.L., and Smeyers-Verbeke J. J Chromatogr. A 874 (2000) 167-185
21. Vander Heyden Y., Nijhuis A., Smeyers-Verbeke J., Vandeginste B.G.M., and Massart D.L. J. Pharm. Biomed. Anal. 24 (2001) 723-753
22. Furlanetto S., Orlandini S., Mura P., Sergent M., and Pinzauti S. Anal. Bioanal. Chem. 377 (2003) 937-944
23. Montgomery D.C. Design and Analysis of Experiments (1976), John Wiley & Sons, Inc., New York, USA